Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 2,3212,340 of 20,252 grants

Active NON-SBIR/STTR RPGS
Actionable categories of avoidable hospital care among adults with cancer
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Nearly all provider groups in Medicare’s five-year Oncology Care Model alternative payment program expressed a goal to reduce hospital use by cancer patien...

$5.56M
USD
Active NON-SBIR/STTR RPGS
Administrative Core
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2023 – 2028

PROJECT SUMMARY The Administrative Core provides strong, centralized scientific and administrative leadership to the PPG, which facilitates synergistic interactions between the fou...

Active NON-SBIR/STTR RPGS
Precision Interception of Gastric Cancer Precursors Through Molecular and Cellular Risk Stratification
NATIONAL CANCER INSTITUTE Stanford University United States 2023 – 2028

ABSTRACT – OVERALL Gastric cancer is a leading cause of cancer morbidity and mortality worldwide. The bacterium Helicobacter pylori (Hp) is the single greatest risk factor for gast...

$17.15M
USD
Active NON-SBIR/STTR RPGS
Project 1 - Molecular and Cellular Determinants of High Risk Gastric Precancerous Lesions
NATIONAL CANCER INSTITUTE Stanford University United States 2023 – 2028

ABSTRACT – PROJECT 1 The main objective of Project 1 is to deconvolute the molecular features of high-risk gastric cancer precursor lesions. Dr. Hanlee Ji, Project Leader, previous...

Active NON-SBIR/STTR RPGS
Broad Genomic Profiling in patients with advanced lung cancer: empirically assessing adoption, clinical utility, and the value of additional evidence in an evolving landscape of cancer care
NATIONAL CANCER INSTITUTE Yale University United States 2023 – 2028

Personalized cancer treatment is becoming a reality. The real-world adoption of broad genomic profiling (BGP) has enabled the simultaneous testing of hundreds of potentially target...

$6.28M
USD
Active NON-SBIR/STTR RPGS
Targeting APOBEC3A-induced genetic heterogeneity and drug resistance in bladder cancer
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2023 – 2028

PROJECT SUMMARY/ ABSTRACT Every five minutes, a new patient is diagnosed with urothelial carcinoma (UC) in the United States, resulting in the death of 18,000 patients annually. Ne...

$4.66M
USD
Active NON-SBIR/STTR RPGS
A Prospective Cohort Study of Patients with Non-Small Cell Lung Cancer and Multiple Myeloma to Assess the Benefits and Harms Related to Cannabis Use During Treatment
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2023 – 2028

With the majority of Americans supporting legalization of medical cannabis, the number of patients asking their clinicians about medical cannabis has also significantly increased....

$5.73M
USD
Active NON-SBIR/STTR RPGS
Digital smoking cessation intervention for nationally-recruited American Indians and Alaska Natives: A full-scale randomized controlled trial
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT (DESCRIPTION) Since the early 1980s, American Indians and Alaska Natives (AIANs) have maintained the highest rates of commercial cigarette smoking of any r...

$6.72M
USD
Active NON-SBIR/STTR RPGS
Pdcd4-Rictor Interaction in Suppression of Lung Tumorigenesis
NATIONAL CANCER INSTITUTE University of Kentucky United States 2023 – 2028

Project Summary/Abstract Lung cancer is the leading cause of cancer-related deaths in the United States. The high mortality rate is not only due to the lack of effective early dete...

$4.82M
USD
Active NON-SBIR/STTR RPGS
Functions of mutant IDH in cholangiocarcinoma
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2023 – 2028

PROJECT SUMMARY Isocitrate dehydrogenase 1 is the most frequently mutated metabolic gene across all cancers. Among epithelial malignancies, IDH1 mutations are particularly common i...

$6.21M
USD
Active OTHER RESEARCH-RELATED
Use and Impact of Quantitative Information in Tobacco Risk Communications
NATIONAL CANCER INSTITUTE Rutgers Biomedical and Health Sciences United States 2023 – 2027

Project Summary/Abstract In 2019, nearly 14 of every 100 U.S. adults aged 18-years or older (14.0%) currently smoked cigarettes. Current strategies of tobacco use risk communicatio...

$878.6K
USD
Active NON-SBIR/STTR RPGS
Assessing Benefits and Harms of Medical Cannabis and Cannabinoid Use in Breast Cancer Patients During and After Treatments
NATIONAL CANCER INSTITUTE University of Miami School of Medicine United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Breast cancer patients represent fast-growing medical cannabis and cannabinoid (MCC) users in this country; a recent survey indicates that about 42% of bre...

$6.64M
USD
Active NON-SBIR/STTR RPGS
Targeting APOBEC3A-induced genetic heterogeneity and drug resistance in bladder cancer
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2023 – 2028

PROJECT SUMMARY/ ABSTRACT Every five minutes, a new patient is diagnosed with urothelial carcinoma (UC) in the United States, resulting in the death of 18,000 patients annually. Ne...

$5.16M
USD
Active NON-SBIR/STTR RPGS
Pdcd4-Rictor Interaction in Suppression of Lung Tumorigenesis
NATIONAL CANCER INSTITUTE University of Kentucky United States 2023 – 2028

Project Summary/Abstract Lung cancer is the leading cause of cancer-related deaths in the United States. The high mortality rate is not only due to the lack of effective early dete...

$4.91M
USD
Active NON-SBIR/STTR RPGS
Role of lipid metabolism in CD8+ T cell ferroptosis
NATIONAL CANCER INSTITUTE Methodist Hospital Research Institute United States 2023 – 2028

PROJECT SUMMARY Recently, we made a novel and exciting discovery that tumors or the tumor microenvironment (TME) cause T- cell dysfunction and death by inducing ferroptosis in T ce...

$4.85M
USD
Active RESEARCH CENTERS
Targeting p300 to Overcome PARP inhibitor resistance induced by acidic tumor microenvironment
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2028

Project 4 PROJECT SUMMARY/ABSTRACT The overall goal of this proposal is to develop a novel strategy to improve efficacy and/or overcome resistance to PARP inhibitors induced by aci...

Active RESEARCH CENTERS
Bioinformatics and Biostatistics Core
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2028

Core B: Bioinformatics and Biostatistics Core SUMMARY/ABSTRACT The primary goal of the Bioinformatics and Biostatistics Core is to provide centralized biostatistics, bioinformatics...

Active RESEARCH CENTERS
Pathology Core
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2028

Core C: Pathology SUMMARY/ ABSTRACT The individual research projects comprising this Ovarian Cancer SPORE application require the procurement, processing, and analysis of histopath...

Completed NON-SBIR/STTR RPGS
Germline Genetics and Risk of Prostate Cancer in Diverse Populations from the All of Us Program
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2023 – 2025

PROJECT SUMMARY Prostate cancer is the second most common cancer and the second leading cause of cancer death in US men, with African American men having the highest incidence and...

$1.93M
USD
Active RESEARCH CENTERS
Shared Resource Core 1: Molecular Data Science and Advanced Dosimetry
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2023 – 2028

PROJECT SUMMARY The convergence of radiation oncology, cancer genomics, data science, computational modeling, and artificial intelligence presents spectacular opportunities and cha...